| Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468) |
|---|
| 01/24/2008 | WO2007126957A3 New compounds |
| 01/24/2008 | WO2007122156A9 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists |
| 01/24/2008 | US20080021217 Heterocyclic inhibitors of rho kinase |
| 01/24/2008 | US20080021033 Immuno Inhibitory Heterocyclic Compounds |
| 01/24/2008 | US20080020985 Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof |
| 01/23/2008 | EP1556354B1 Therapeutic piperazine derivates useful for treating pain |
| 01/22/2008 | US7320977 Substituted 2-phenyl-3(2h)-pyridazinones |
| 01/17/2008 | US20080015193 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080015172 Caspase inhibitors and uses thereof |
| 01/17/2008 | US20080015169 Amino-methyl substituted tetracycline compounds |
| 01/16/2008 | EP1786823B1 Alkylidene tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents |
| 01/15/2008 | US7319111 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists |
| 01/15/2008 | US7319105 Cytotoxic agents |
| 01/15/2008 | US7319104 hPPARs activators |
| 01/15/2008 | US7319099 Benzoyl-piperazine derivatives |
| 01/15/2008 | CA2334864C A reference compound for use in the analysis of levosimendan batches |
| 01/10/2008 | WO2008003611A1 Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11b-hsd 1) |
| 01/10/2008 | US20080009621 Control of Cyanate in Aqueous Urea Solutions by non-1,2-Ethylene Diamine like Compounds for the Protection of Protein/Peptide Carbamylation |
| 01/10/2008 | US20080009499 3-(2,2-Dimethyl-propyl)-5,6,7,8,9,10-hexahydro-cycloocta[c]pyridazine; 11beta-hydroxysteroid dehydrogenase (11b-HSD1) inhibitors; diabetes, obesity, eating disorders, dyslipidemiae and hypertension |
| 01/10/2008 | US20080009498 Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use |
| 01/09/2008 | EP0850227B1 Pyridazin-3-one derivatives, their use, and intermediates for their production |
| 01/09/2008 | CN101099740A Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 01/02/2008 | EP1873147A1 Phthalazinone derivative and pharmaceutical comprising the same |
| 01/02/2008 | EP1871749A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 01/01/2008 | US7314933 Vanilloid receptor ligands and their use in treatments |
| 12/27/2007 | US20070299263 Hydroxy Alkyl Amines |
| 12/27/2007 | US20070299081 Heterocyclic Derivatives and Their Use as Mediators of Stearoyl-Coa Desaturase |
| 12/27/2007 | US20070299080 Benzamide derivatives and uses related thereto |
| 12/27/2007 | US20070299074 Guanidine Compounds, and Use Thereof as Binding partners for 5-Ht5 Receptors |
| 12/27/2007 | US20070299064 Pesticidal Heterocyclic Dihaloallyl Compounds |
| 12/26/2007 | CN101094837A Novel beta agonists, method for producing the same and their use as drugs |
| 12/25/2007 | US7312328 Antiinflammatory agents; autoimmune disease; rheumatic diseases; multiple sclerosis; respiratory system disorders |
| 12/25/2007 | US7312234 Chemokine receptor binding heterocyclic compounds |
| 12/25/2007 | US7311736 Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetra-azapentamethine compounds |
| 12/21/2007 | WO2007144200A1 Process for the covalent coupling of two molecules by means of a diels-alder reaction with inverse electron requirement |
| 12/21/2007 | WO2007123939A3 Novel arylamino n-heteraryls as mek inhibitors |
| 12/20/2007 | US20070293669 Invertible amphiphilic polymers |
| 12/19/2007 | EP1867638A1 Procedure for the Conection of two Molecules via Diels-Alder Reactions with Inverse Electron Demand |
| 12/19/2007 | EP1865775A1 Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors |
| 12/19/2007 | EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/19/2007 | CN101090883A Substituted hydroxyethylamines |
| 12/18/2007 | US7309701 inhibitors of glycogen synthase kinase-3 beta; treatment of diabetes or neurodegenerative diseases such as Alzheimer's disease; 6-(2-butylamino-pyrimidin-4-yl)-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid (3-pyridin-3-yl-propyl)-amide, as example |
| 12/13/2007 | WO2007044796A3 Pyridazinone compounds as calcilytics |
| 12/13/2007 | US20070287709 Novel arylamino N-heteraryls as MEK inhibitors |
| 12/13/2007 | US20070287707 Phosphodiesterase 10 inhibitors |
| 12/13/2007 | US20070287697 Cgrp Receptor Antagonists |
| 12/12/2007 | EP1864663A1 Preventive and/or therapeutic agent for rheumatoid arthritis |
| 12/12/2007 | EP1268481B1 Kinase inhibitors as therapeutic agents |
| 12/12/2007 | CN101087766A Pyridazine compounds, compositions and methods |
| 12/12/2007 | CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 12/12/2007 | CN101085759A Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 12/12/2007 | CN100354267C Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds |
| 12/11/2007 | US7307087 Antidepressants; analgesics; antiinflammatory agents; side effect reduction |
| 12/11/2007 | US7307080 Nuclear enzyme poly(adenosine 5'-diphospho-ribose) polymerase inhibitors; protection against ill effects of reactive free radicals and nitric oxide |
| 12/11/2007 | CA2393271C Retroviral protease inhibiting compounds |
| 12/06/2007 | WO2007138242A1 Biphenyl derivatives and their use in treating hepatitis c |
| 12/06/2007 | CA2653924A1 Biphenyl derivatives and their use in treating hepatitis c |
| 12/06/2007 | CA2653529A1 Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 12/05/2007 | EP1862461A1 Method for producing 3,6-dichloropyridazine-1-oxide |
| 12/05/2007 | EP1861379A1 Tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents |
| 12/05/2007 | CN101083993A Heterocyclic derivatives and their use as therapeutic agents |
| 12/05/2007 | CN101083992A Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
| 12/04/2007 | US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 12/04/2007 | US7304059 Substituted quinazolin-4-ylamine analogues |
| 11/29/2007 | WO2007136626A1 Solid dosage formulations of hydralazine compounds |
| 11/29/2007 | CA2652135A1 Solid dosage formulations of hydralazine compounds |
| 11/28/2007 | EP1858860A1 Phthalazinones |
| 11/28/2007 | CN100351253C Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents |
| 11/27/2007 | US7301022 N-(2-(6-7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-ylamino)pyrimidin-4-yl)-5-(trifluoromethyl)phenyl)-1-isopropylpyrrolidine-2-carboxamide hydrochloride; antiinflammatory agents, analgesics, antiarthritic agents, antiulcer agents |
| 11/27/2007 | US7300935 Gonadotropin-releasing hormone antagonistic activity, therapy of prostatic cancer, endometriosis, precocious puberty; N-(4-(1-(2,6-difluorobenzyl)-5-(((2-ethoxyethyl)(methyl)amino)methyl)-2,4-dioxo-3-(2-pyridinyl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea |
| 11/27/2007 | US7300932 For treatment or prevention of metabolic and cell proliferative diseases; modifying lipid metabolism |
| 11/27/2007 | US7300921 with antibiotic activity; made by cultivation of Amycolatopsis orientalis |
| 11/22/2007 | WO2007075783A3 Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitor |
| 11/21/2007 | EP1856063A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 11/21/2007 | EP1856058A2 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
| 11/21/2007 | EP1856053A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity |
| 11/15/2007 | US20070265273 Pyrimidin-2-Amine Derivatives and Their Use as A2b Adenosine Receptor Antagonists |
| 11/15/2007 | US20070265270 Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| 11/15/2007 | US20070265256 Phosphodiesterase 10 inhibitors |
| 11/15/2007 | US20070265241 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 11/14/2007 | EP1853566A1 Cinnoline compounds and their use as liver x receptor modulators |
| 11/14/2007 | EP1689231A4 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 11/14/2007 | CN100348587C Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 11/13/2007 | US7294718 Synthesis of a 4-methylthiazole-4(S)-carboxylic acid compound |
| 11/13/2007 | US7294642 1,3-Diamino-2-hydroxypropane pro-drug derivatives |
| 11/13/2007 | US7294626 4-(6-(p-substituted phenyl)-3-pyridazinyl)-1-isopropylpiperazines, e.g., 4-[6-(4-Isopropylpiperazin-1-yl)-pyridazin-3-yl]benzonitrile; treatment of diseases or disorders related to the histamine H3 receptor, e.g., obesity, eating disorders, osteoarthritis, type 2 diabetes, allergic rhinitis, & narcolepsy |
| 11/13/2007 | US7294624 Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases |
| 11/08/2007 | WO2007126957A2 New compounds |
| 11/08/2007 | WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity |
| 11/08/2007 | CA2650683A1 Amine derivative having npy y5 receptor antagonist activity |
| 11/07/2007 | EP1851210A2 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| 11/07/2007 | EP1851205A2 Pyridazine derivatives and their use as therapeutic agents |
| 11/07/2007 | EP1851204A1 Naphthalene derivatives as modulators of the glucocorticoid receptor |
| 11/07/2007 | EP1087941B9 Thiolesters and uses thereof |
| 11/07/2007 | CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 11/06/2007 | US7291729 Reacting 2,3,4-trifluoronitrobenzene with an alkali metal aryloxide, contacting the 3,4-difluoro-2-aryloxynitrobenzene produced with an alkali metal salt of a malonate diester to replace the 4-fluoro group with the malonate; optional further hydrolysis, reduction of the NO2 group, and decarboxylation |
| 11/01/2007 | WO2007123939A2 Novel arylamino n-heteraryls as mek inhibitors |
| 11/01/2007 | WO2007122156A1 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists |
| 11/01/2007 | WO2007121668A1 Direct chemiluminescent reagent for magnetic separation and immunoassay method using thereof |